文献速递慢性肾脏病肾小球疾病

循环Ephrin-Eph信号反映糖尿病肾病间质纤维化与肾小管萎缩

Circulating Ephrin-Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-08-21

在129例活检确诊糖尿病肾病的韩国患者中,基于SomaScan的血浆蛋白质组学分析发现ephrin受体信号通路是与IFTA面积正相关且上调的最强通路。该关联在KPMP(n=73)和Boston Kidney Biopsy Cohort(n=414)两个外部队列中验证,并与肾衰竭风险升高相关。肾脏多组学分析将ephrin-Eph信号与上皮-间质转化相关分子程序联系起来。

要点

  • 循环ephrin-Eph信号是反映糖尿病肾病IFTA负担的稳健血浆蛋白质组学特征。
  • 该信号通路高活性与后续肾衰竭风险升高相关。
  • 肾脏EPHA4和EPHB1表达与上皮-间质转化特征及缺氧、JAK-STAT、TGFβ通路激活相关。

核心结论

  • ephrin受体信号通路上调是反映糖尿病肾病IFTA的稳健且可重复的血浆蛋白质组学特征。

研究设计与样本

  • 在首尔国立大学医院129例活检确诊糖尿病肾病患者中进行SomaScan血浆蛋白质组学分析,并在KPMP(n=73)和Boston Kidney Biopsy Cohort(n=414)两个外部队列中验证。

主要发现

  • 在首尔国立大学医院糖尿病肾病队列中,ephrin受体信号通路是与IFTA面积正相关且在糖尿病肾病患者中上调的最强通路。
  • 该关联在KPMP和Boston Kidney Biopsy Cohort队列中重复验证。
  • ephrin受体信号通路高活性与肾衰竭风险升高相关。
  • 糖尿病肾脏中ephrin-Eph信号组分表达升高,尤其是编码EPHA4和EPHB1的基因。
  • 这些基因的肾脏表达与上皮-间质转化特征相关,并伴随缺氧、JAK-STAT和TGFβ信号通路在多种肾脏细胞类型中的下游激活。

临床怎么用

  • 循环ephrin-Eph信号有望作为无创生物标志物反映糖尿病肾病IFTA负担并预测肾衰竭风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: The ephrin-Eph signaling pathway emerged as the strongest blood proteomic correlate of interstitial fibrosis and tubular atrophy burden in a biopsy-confirmed diabetic kidney disease cohort. This association was independently validated in 2 external multiethnic cohorts and was associated with a higher risk of subsequent kidney failure. Kidney multiome analyses linked ephrin-Eph signaling to intrarenal epithelial-mesenchymal transition-related molecular programs in diabetic kidney. BACKGROUND: Diabetic kidney disease (DKD) is characterized by heterogeneous renal histological patterns, among which interstitial fibrosis and tubular atrophy (IFTA) is a key determinant of patient outcomes and treatment response. However, blood biomarkers reflecting IFTA burden remain unestablished. METHODS: We conducted SomaScan-based blood proteomic profiling in Korean patients with biopsy-confirmed diabetic nephropathy from the Seoul National University Hospital ( n =129). Linear regression analyses were used to identify pathways associated with IFTA area, and those additionally upregulated compared with healthy individuals were prioritized. Findings were validated in 2 external cohorts with available SomaScan data and histologic IFTA assessment: the Kidney Precision Medicine Project (KPMP; n =73) and the Boston Kidney Biopsy Cohort ( n =414). Renal expression and downstream signaling of pathway components were evaluated using human kidney multiome data from KPMP. RESULTS: In the diabetic nephropathy from Seoul National University Hospital cohort, the ephrin receptor signaling pathway emerged as the top pathway both positively associated with IFTA area and upregulated in patients with DKD. This association was replicated in the KPMP and Boston Kidney Biopsy Cohort cohorts. High activity of the ephrin receptor signaling pathway was also associated with a higher risk of kidney failure. Kidney tissue analyses demonstrated a higher expression of ephrin-Eph signaling components, particularly genes encoding EPHA4 and EPHB1, in diabetic kidneys. Renal expression of these genes correlated with epithelial-mesenchymal transition signatures, accompanied by downstream activation of hypoxia, Janus kinase-signal transducer and activator of transcription, and TGF β signaling pathways across multiple kidney cell types. CONCLUSIONS: Upregulation of the ephrin receptor signaling pathway represents a robust and reproducible blood proteomic signature reflecting IFTA in DKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Han SS, Surapaneni AL, Schmidt IM, et al. Circulating Ephrin-Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2026. PMID: 42627699. doi:10.2215/CJN.0000001191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。